Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT03513484 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03513484
Sponsor: Northwestern University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Fibroblast Growth Factor Basic Form Measurement FLT3 Internal Tandem Duplication Recurrent Adult Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia

Start date: 2018-11-14
Primary completion: 2023-12-11
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.